NewHold Investment Corp IV(NHIV) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 4:10 PM ET (Korea 9/12 05:10)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | - | Insider Own | 26.02% | Shs Outstand | 20.8M | Perf Week | 0.4% |
| Market Cap | 0.28B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 20.3M | Perf Month | 0.1% |
| Enterprise Value | 0.28B | PEG | - | EPS next Q | - | Inst Own | 47.33% | Short Float | - | Perf Quarter | 1.4% |
| Income | - | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 0.01 | Perf Half Y | - |
| Sales | - | P/B | 1.42 | EPS next 5Y | - | ROA | - | Short Interest | 0.00M | Perf YTD | -3.43% |
| Book/sh | 7.17 | P/C | 209.47 | EPS past 3/5Y | - | ROE | - | 52W High | -11.83% ($11.50) | Perf Year | - |
| Cash/sh | 0.05 | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 3.47% ($9.80) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | - | Volatility(W/M) | 0.04% 0.09% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.05 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 4.07 | EPS Q/Q | - | Profit Margin | - | RSI (14) | 56.72 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.07 | Sales Q/Q | - | SMA20 | 0.32% ($10.11) | Beta | - | Target Price | - |
| Payout | - | Debt/Eq | 0 | Earnings | - | SMA50 | 0.61% ($10.08) | Rel Volume | 0 | Prev Close | $10.05 |
| Employees | 3 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | 0.61% ($10.08) | Avg Volume(3M) | 0.04M | Price | $10.14 |
| IPO | 2026/6/8 | Option/Short | No/Yes | Trades | 11 | Volume | 13 | Change | 0.89% |
Company
NHIV is a Financial sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🤝 This is a special purpose acquisition company (SPAC) formed for the purpose of corporate acquisitions. Without engaging in direct business operations, the company deposits funds raised through its IPO into a trust account, with the goal of identifying merger targets in the growing industrials and business services sectors. Backed by the industry experience of a sponsor team that has operated multiple SPACs, it is a blank-check company pursuing a listing through a merger.
Over the past 1 year, on the lower side
12% below its 1-year high.
NHIV makes money exceptionally well
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Long-term returns are close to the market
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 47.3%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
SPAQ 0.05%It ranks #4 in the industry
Based on market cap of $279M.
NHIV $279M PER -
LION $3B PER -
BBCQ $2B PER -
CCXI $686M PER -
FAQ
What kind of company is NHIV?
NHIV belongs to the Financial sector and operates in the Shell Companies industry.
What is the market cap of NHIV?
The market cap of NHIV is approximately $279M, ranking 3,818 within its sector.
What is the 52-week high and low for NHIV?
NHIV has recorded a 52-week high of $11.50 and a low of $9.80.
